Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 58 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
PHARMES BELGIË from Wielsbeke, company number BE1008128324, closed financial year 2025 with a result of € 13,978 after tax. For that financial year PHARMES BELGIË recorded a gross margin of € 66,183 and equity of € 17,978. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 25, 2026.
€ 17,978
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 13,978
Profit after tax over the fiscal year.
€ 32,520
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 13,978.
People and assets in 2025
€ 24,576
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 81,272
Of which on lease € 31,337.
Debts at end 2025
€ 83,019
€ 23,077 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 169,573
Supplier invoices still open on the last day of the fiscal year.
€ 6,639
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to PHARMES BELGIË?
What happened at PHARMES BELGIË in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 13,978. Source: NBB ↗
- New establishment in Wielsbeke. KBO
- Start of the company according to the CBE. KBO
In short
Paid € 4,743 in corporate taxes since 2025.
A new publication or filing at PHARMES BELGIË? We notify you, reason included.
Follow PHARMES BELGIËDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PHARMES BELGIË are Mathieu Dejager and Pieter Dombrecht. The same people are also behind FASSADE and VAMOS IMMO. Mathieu Dejager is also behind MCD. Pieter Dombrecht is also behind PIETER DOMBRECHT.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Tumulusstraat 4
8710 Wielsbeke
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Barracuda
Hosting
AS-VULTR - The Constant Company, LLC, US
Website info
Features
Security
Details
- Company number
- 1008.128.324
- VAT number
- BE 1008.128.324
- Registered office
- Tumulusstraat 4, 8710 Wielsbeke
- Names & denominations
- PHARMES BELGIË
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 8 April 2024
- Peppol
- Active · Active since 4 Dec 2025
- Contact
- pharmes.be
- Activities · NACE
Groothandel in kantoor- en winkelmeubelen
Overige bouwinstallatie
Overige bouwinstallatie, n.e.g.
Handelsbemiddeling in de groothandel in andere specifieke goederen
Overige gespecialiseerde ontwerpactiviteiten
Overige activiteiten van gespecialiseerde designers